Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IDA | 0.02% | $6.18B | +22.91% | 2.99% |
VHC | 0.07% | $45.90M | +59.26% | 0.00% |
WELL | -0.07% | $99.49B | +45.93% | 1.77% |
KVUE | -0.10% | $40.09B | +14.85% | 3.94% |
NEUE | 0.17% | $61.96M | +27.57% | 0.00% |
KGC | 0.17% | $18.24B | +78.73% | 0.80% |
UL | -0.20% | $149.53B | +10.78% | 3.18% |
AGL | 0.23% | $956.23M | -64.68% | 0.00% |
MCD | 0.28% | $208.47B | +14.41% | 2.39% |
HTO | -0.29% | $1.77B | -4.41% | 3.14% |
EW | 0.31% | $45.88B | -15.33% | 0.00% |
FTS | -0.31% | $23.66B | +21.42% | 3.69% |
ATO | 0.32% | $24.22B | +30.72% | 2.24% |
SAND | -0.39% | $2.65B | +65.99% | 0.63% |
BTCT | 0.40% | $18.98M | +37.85% | 0.00% |
PRA | -0.40% | $1.17B | +86.82% | 0.00% |
ABT | -0.40% | $233.80B | +29.32% | 1.70% |
NGD | 0.42% | $3.76B | +143.59% | 0.00% |
GALT | 0.42% | $147.47M | +3.10% | 0.00% |
IAG | 0.44% | $4.07B | +88.80% | 0.00% |
Current Value
$3.721 Year Return
Current Value
$3.721 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CME | -22.52% | $99.01B | +39.76% | 3.87% |
CBOE | -21.53% | $23.98B | +34.66% | 1.10% |
AWK | -15.35% | $26.90B | +6.78% | 2.27% |
ED | -14.37% | $35.36B | +9.76% | 3.39% |
EXC | -13.90% | $43.32B | +23.98% | 3.65% |
MO | -13.53% | $98.96B | +28.98% | 6.98% |
KR | -13.34% | $47.56B | +43.04% | 1.79% |
CL | -11.30% | $71.89B | -8.58% | 2.28% |
MDLZ | -10.78% | $87.76B | +3.58% | 2.73% |
DUK | -10.64% | $90.88B | +16.65% | 3.59% |
TMUS | -10.60% | $267.11B | +33.53% | 1.40% |
AMT | -10.57% | $101.95B | +12.04% | 3.05% |
T | -10.42% | $202.05B | +46.94% | 3.95% |
PPC | -9.87% | $10.57B | +30.66% | 0.00% |
TEF | -9.85% | $29.29B | +23.28% | 6.30% |
PGR | -9.63% | $154.76B | +27.10% | 1.86% |
KO | -9.55% | $302.72B | +10.49% | 2.83% |
DFDV | -9.14% | $247.94M | +1,821.34% | 0.00% |
MCK | -9.00% | $90.65B | +24.27% | 0.39% |
LITB | -8.49% | $21.70M | -78.27% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XNCR | 52.20% | $579.33M | -57.00% | 0.00% |
BEAM | 47.65% | $1.69B | -28.30% | 0.00% |
NRIX | 47.52% | $887.38M | -44.23% | 0.00% |
IPGP | 47.33% | $2.91B | -18.81% | 0.00% |
IMNM | 46.92% | $763.10M | -27.52% | 0.00% |
COGT | 46.42% | $808.38M | -15.78% | 0.00% |
MGNX | 45.94% | $75.08M | -72.00% | 0.00% |
DNLI | 45.32% | $2.05B | -39.28% | 0.00% |
IDYA | 45.29% | $1.87B | -39.13% | 0.00% |
REAL | 44.60% | $553.03M | +53.29% | 0.00% |
ETD | 44.34% | $710.01M | +1.47% | 5.52% |
RGNX | 44.32% | $422.76M | -28.29% | 0.00% |
COHU | 44.29% | $901.22M | -41.45% | 0.00% |
CDXS | 43.81% | $198.00M | -22.90% | 0.00% |
ROG | 43.23% | $1.27B | -43.16% | 0.00% |
CRBU | 43.13% | $117.19M | -23.17% | 0.00% |
ASB | 42.78% | $4.05B | +15.56% | 3.70% |
RXRX | 42.73% | $2.04B | -32.93% | 0.00% |
CTS | 42.67% | $1.30B | -13.85% | 0.46% |
DKS | 42.51% | $16.24B | -5.60% | 2.27% |
Finnhub
THE OPHTHALMOLOGY MEDICINES COMPANY A First-in-Class Investigational Bispecific Intravitreal Biologic for the Treatment of Macular Edema Secondary to Inflammation ...
Yahoo
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management along with key opinion leaders will present KSI-101 highlights at the 2025 Congress of the International Ocular Inflammation Society (IOIS) in Rio de Janeiro, Brazil on Friday, June 27, 2025.
Yahoo
The global age-related vision dysfunction (ARVD) market is witnessing robust growth due to the aging population and heightened awareness of eye health. Age-related vision dysfunction encompasses impairments like macular degeneration, cataracts, and glaucoma, affecting quality of life. The market is thriving with innovative solutions, including pharmaceuticals, surgeries, and digital health technologies such as AI diagnostics and telemedicine. Despite economic and regulatory hurdles, advancements
SeekingAlpha
Baker Brothersâ Q1 2025 portfolio reveals biotech investment trends. See more on their top holdings, stake changes, and high-conviction strategies.
Yahoo
Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SeekingAlpha
EyePoint Pharmaceuticals' Duravyu shows promising Phase 2 results in DME, with potential for less frequent dosing. Check out why EYPT stock is a buy.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ITM | -0.01% | $1.87B | 0.18% |
TIPX | 0.02% | $1.67B | 0.15% |
JUCY | -0.07% | $271.76M | 0.6% |
IBND | -0.10% | $378.69M | 0.5% |
AGZD | -0.10% | $102.66M | 0.23% |
TBLL | -0.10% | $2.13B | 0.08% |
UBND | 0.13% | $1.02B | 0.4% |
IBMS | 0.14% | $88.22M | 0.18% |
ISTB | -0.16% | $4.45B | 0.06% |
GBIL | 0.17% | $6.38B | 0.12% |
BIL | -0.21% | $42.87B | 0.1356% |
GNMA | -0.23% | $368.58M | 0.1% |
RING | -0.25% | $1.47B | 0.39% |
EUSB | 0.26% | $734.55M | 0.12% |
EAGG | -0.27% | $3.99B | 0.1% |
SCHZ | 0.29% | $8.59B | 0.03% |
TFLO | 0.30% | $6.83B | 0.15% |
CLIP | -0.37% | $1.52B | 0.07% |
PZA | 0.39% | $2.84B | 0.28% |
NEAR | -0.42% | $3.31B | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 53.92% | $44.43M | 0.5% |
XBI | 52.99% | $4.95B | 0.35% |
ARKG | 51.90% | $1.05B | 0.75% |
IWC | 50.72% | $824.65M | 0.6% |
IBB | 49.09% | $5.36B | 0.45% |
KJUL | 46.78% | $120.75M | 0.79% |
IWO | 46.29% | $11.48B | 0.24% |
VTWO | 46.27% | $13.29B | 0.07% |
IWM | 46.23% | $64.00B | 0.19% |
PBE | 45.90% | $223.24M | 0.58% |
GSSC | 45.32% | $586.95M | 0.2% |
SCHA | 45.27% | $17.26B | 0.04% |
IWN | 45.11% | $10.89B | 0.24% |
NUSC | 44.53% | $1.13B | 0.31% |
QQQJ | 44.51% | $617.03M | 0.15% |
ESML | 44.40% | $1.84B | 0.17% |
ARKK | 44.40% | $6.89B | 0.75% |
PRFZ | 44.31% | $2.36B | 0.34% |
XTN | 44.31% | $170.57M | 0.35% |
FYX | 44.19% | $819.32M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -41.90% | $296.79M | 1.43% |
VIXY | -33.52% | $165.69M | 0.85% |
TAIL | -31.91% | $99.76M | 0.59% |
FXY | -18.43% | $815.67M | 0.4% |
FTSD | -15.37% | $231.79M | 0.25% |
IVOL | -13.21% | $349.27M | 1.02% |
LDUR | -12.34% | $929.55M | 0.5% |
UTWO | -12.31% | $379.36M | 0.15% |
CANE | -11.97% | $10.44M | 0.29% |
XONE | -10.98% | $585.86M | 0.03% |
SCHO | -10.92% | $11.46B | 0.03% |
ULST | -10.65% | $662.59M | 0.2% |
SPTS | -10.36% | $5.78B | 0.03% |
IBTH | -10.31% | $1.60B | 0.07% |
XHLF | -10.24% | $1.73B | 0.03% |
VGSH | -9.93% | $22.80B | 0.03% |
IEI | -9.40% | $15.37B | 0.15% |
UDN | -9.38% | $147.88M | 0.78% |
IBTM | -9.22% | $316.18M | 0.07% |
VGIT | -9.05% | $31.83B | 0.04% |